Mustafa Khasraw, MD. He is a medical oncologist, neuro-oncologist, and Deputy Director of the Center for Cancer Immunotherapy, Duke Cancer Institute. He is the lead principal investigator on phase I, II, and III multi-center clinical trials for several pharmaceutical and academic groups. He chairs the Clinical Trials Track for the Society of Neuro-Oncology (SNO), serves as advisor and grant reviewer for several non-profits and patient advocacy groups, and is a Fellow of the Royal Australasian College of Physicians and an Elected Fellow of the Royal College of Physicians (UK).
Mustafa Khasraw, MD. He is a medical oncologist, neuro-oncologist, and Deputy Director of the Center for Cancer Immunotherapy, Duke Cancer Institute. He is the lead principal investigator on phase I, II, and III multi-center clinical trials for several pharmaceutical and academic groups. He chairs the Clinical Trials Track for the Society of Neuro-Oncology (SNO), serves as advisor and grant reviewer for several non-profits and patient advocacy groups, and is a Fellow of the Royal Australasian College of Physicians and an Elected Fellow of the Royal College of Physicians (UK).